Tate & Lyle (TATYY)
(Delayed Data from OTC)
$41.45 USD
+1.19 (2.96%)
Updated Nov 7, 2024 03:31 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Tate & Lyle PLC falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 2,070 | 2,110 | 1,878 | 3,672 | 3,664 |
Cost Of Goods | 1,001 | 1,056 | 951 | 1,965 | 1,863 |
Gross Profit | 1,070 | 1,055 | 927 | 1,707 | 1,802 |
Selling & Adminstrative & Depr. & Amort Expenses | 810 | 818 | 836 | 1,332 | 1,432 |
Income After Depreciation & Amortization | 260 | 236 | 92 | 375 | 370 |
Non-Operating Income | 55 | -14 | 1 | 35 | 48 |
Interest Expense | 31 | 39 | 36 | 41 | 42 |
Pretax Income | 284 | 183 | 57 | 370 | 376 |
Income Taxes | 59 | 30 | 22 | 39 | 65 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 225 | 153 | 36 | 331 | 311 |
Extras & Discontinued Operations | 11 | 76 | 287 | 0 | 0 |
Net Income (GAAP) | 236 | 229 | 322 | 331 | 311 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 378 | 351 | 228 | 604 | 589 |
Depreciation & Amortization (Cash Flow) | 118 | 115 | 137 | 229 | 219 |
Income After Depreciation & Amortization | 260 | 236 | 92 | 375 | 370 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 101.05 | 102.81 | 117.60 | 100.58 | 100.84 |
Diluted EPS Before Non-Recurring Items | 2.79 | 2.40 | 1.36 | 3.75 | 3.45 |
Diluted Net EPS (GAAP) | 2.34 | 2.23 | 2.74 | 3.29 | 3.09 |
Fiscal Year end for Tate & Lyle PLC falls in the month of March .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |